Skip to main content

Table 1 Clinical and histopathological characteristics of breast cancer patients involved in microarray analysis

From: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis

No Diagnosis Grade1 AC LN ER3 PgR3 HER-2 Bcl-2 E-CD
1 IDC G3 IDH N1 0 0 0 80% >90%
2 IDC G2 none N1 40% 0 0 80% >90%
3 IDC G2 none N0 10% 2% 0 70% >90%
4 IDC G3 none N0 90% 50% 2+ 2 100% >90%
5 IDC G2 DCIS N0 90% 1% 0 95% >90%
6 ILC G2 LCIS N0 0 0 0 30% 0
7 ILC G1 none N0 80% 80% 0 100% 0
8 ILC G1 none N1 50% 0 0 80% 0
9 ILC G2 LCIS N1 0 0 0 <5% 0
10 ILC G1 none N0 50% 70% 0 80% 0
  1. 1Tumors were graded using the Nottingham combined histologic grading system.
  2. 2No gene amplification was detected by fluorescent in situ hybridization.
  3. 3A complete H-score was calculated by summing the products of the percentage cells stained at a given staining intensity (0–100) and the staining intensity (0–3).
  4. AC, accompanying changes; DCIS, ductal carcinoma in situ; E-CD, E-cadherin; ER, estrogen receptor; IDC, invasive ductal carcinoma, IDH, intraductal hyperplasia; ILC, invasive lobular carcinoma; LCIS, lobular carcinoma in situ; LN, lymph node; PgR, progesterone receptor.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us